BACKGROUND: high-resolution anoscopy is increasingly advocated to screen hiV+ men who have sex with men for anal cancer and its precursor lesions, anal intraepithelial neoplasia. a systematic comparison between clinical features and the histopathology of suspect lesions is lacking.
a nal cancer is an increasing problem among patients with hiV, especially among hiV-positive men who have sex with men (msm) with incidence rates of 65 to 109 per 100,000 person-years. 1 this is much higher than the incidence of cervical cancer in hiV-negative women before standard cytological screening was introduced; therefore, routine screening for anal premalignant lesions is subject of discussion. 2 as with cervical cancer, anal cancer is preceded by a precursor called anal intraepithelial neoplasia (ain). this is graded as ain 1 (mild), ain 2 (moderate), and ain 3 (severe). [3] [4] [5] ain 1 is increasingly being referred to as low-grade ain (lGain) and ain 2/3 as high-grade ain (hGain). the majority of hiV+ msm has ain, and hGain is seen in 25% to 52%. [6] [7] [8] for hGain, the progression rates to anal cancer have been reported to be 14% and 16% in hiV+ msm, with median follow-ups of 2 and 5 years. 9,10 the standard for ain detection is highresolution anoscopy (hRa) in combination with biopsies and histopathological analysis of suspect lesions. 11 Given the high prevalence of hGain and low specificity of anal cytology, 8 hRa in combination with histopathological examination of lesional biopsies is likely to be the preferable first-line hGain screening method in hiV+ msm. Currently, only a limited number of physicians are experienced in hRa, and training programs should be implemented to facilitate future ain screening. however, hRa is a complicated procedure, and no guidelines exist to identify lesions suspect for ain. to our knowledge, only 1 clinically relevant paper on the systematic comparison of clinical features with pathological outcome has been published. 12 more information on the challenges and pitfalls in hRa are needed for the development of screening algorithms and guidelines. until now, hRa evaluation of the anal mucosa has been based on guidelines for the colposcopic detection of cervical intraepithelial neoplasia (Cin), yet the experience from Cin-screening cervical colposcopy is of limited use for hRa. for example, in the evaluation of Cin lesions, an overview image of the complete cervix can be obtained, allowing the evaluation of suspected lesions in 1 picture. in contrast, in the evaluation of ain lesions, an overview of the complete transformation zone in the anal canal cannot be obtained because of the folded nature of the anal mucosa. as a consequence, the anal transformation zone has to be evaluated in consecutive images to get a full picture of possible ain involvement.
in this study of hRa in hiV+ msm, we analyzed interobserver agreement in classifying features of intra-anal lesions suspect for ain and compared the features of lesions suspect for ain with their histopathological outcome.
METHODS
the study was performed at the hiV and dermatology outpatient clinics of the academic medical Center in amsterdam, the netherlands. hiV+ msm older than 18 years were eligible if they did not have a history of anal cancer or current active IBD. Patients who fulfilled the criteria were asked by their hiV physician to participate in our hRa cohort. they were not specifically referred for anal concerns or previous anal pathology. eligible for the present substudy were participants in whom biopsies were taken from suspect lesions and good-quality images were available. all patients provided written informed consent, and the study was approved by the local ethics committee. a single hRa-experienced physician (o.R.) performed hRa as described previously, with magnification up to ×17.7. 13, 14 after the application of acetic acid 3%, suspect intra-anal lesions (if present) were photographed and biopsied for histopathological analysis. a single pathologist (C.V.N.) evaluated all biopsies by using Ki-67 and p16 immunostaining. 15 the physician who performed hRa was not participating in the analysis of interobserver agreement because of his knowledge of the participants and pathological outcomes. he blinded all images and marked the locations where biopsies were taken. images that were out of focus were left out of the analysis. two dermatologists experienced in HRA (H.D.V., A.K.), from 2 different centers, judged the images on macroscopic appearance of the suspect lesions without knowledge of the pathological outcome. lesions were classified as being condylomatous or flat (noncondylomatous). this classification was followed by a subclassification of flat lesions, distinguishing abnormal surface configuration (acetowhitening, flat leukoplakia, hyperkeratotic leukoplakia), punctation, mosaicism, and atypical vessels as previously described for cervical suspect lesions. 16 in a first round, classification was performed by the 2 dermatologists independently from each other. these data were used in the interobserver agreement analysis. in a second classification round (consensus meeting), the 2 dermatologists jointly characterized the lesions they disagreed on in the first round. after this second round, all lesions they agreed upon were linked to their pathological outcome. if no agreement was reached, lesions were excluded from further analyses.
for each characteristic, interobserver agreement was analyzed by the Cohen κ-coefficient with se. 17 for all lesional characteristics on which agreement was reached, the positive predictive value (PPV) for LGAIN and HGAIN was calculated, with 95% Cis. this calculation was repeated for clusters of characteristics. statistical analyses were performed by using SPSS software (version 16.0.2 for Windows; IBM SPSS Statistics, IBM Corporation, armonk, nY).
RESULTS
Between march 2008 and December 2010, 650 hiV+ msm were screened for eligibility; of these patients, 191 were not interested, 14 fulfilled the exclusion criteria, and 57 had significant comorbidity according to their treating physician. the remaining 388/650 (60%) hiV+ msm were screened for AIN. Patients in whom no biopsies were taken (n = 19) were left out, as well as patients in whom no hRa-guided images were taken (n = 180), because no visual-recording equipment was yet available, or images were of insufficient quality (n = 26). the remaining 163/388 (42%) patients were included in the present analysis ( fig. 1 ).
anal intraepithelial neoplasia was found in 116/163 patients (71%) and hGain was found in 62/163 (38%). Baseline characteristics of the patients can be found in table 1. in total, 304 biopsies were taken. one-hundred sixty eight (55%) showed ain, and hGain was seen in 67/304 (22%). three hundred one images of the 304 lesions were analyzed. the study flowchart is presented in figure 2 .
in the first, independent classification round, the 2 dermatologists agreed in 85% (259/304) of cases in classifying a lesion as condylomatous or flat. after correction for expected agreement, this leads to a κ-coefficient of 0.65. in noncondylomatous (flat) lesions, surface configuration, punctation, mosaicism, and atypical vessels showed κcoefficients of 0.14, 0.54, 0.08, and 0.43. the observed agreement for both surface configuration and mosaicism was 72% and 92%, but the expected agreement was almost similar, leading to the poor κ coefficient (table 2) .
in the second, joint round of classification, the 2 dermatologists agreed upon all lesions but 2 (both healthy mucosa on histopathological analysis), which were excluded from the following analyses. of the 302 lesions, 90 (30%) were classified as condylomatous. of those, 13 (14%) did not show ain, 61 (68%) showed lGain, and 16 (18%) showed hGain. in contrast, 24% of all hGain lesions were condylomatous.
two hundred twelve lesions of 302 (70%) were classified as flat. of those, acetowhitening was seen in 28 (13%), flat leukoplakia in 161 (76%), hyperkeratotic leukoplakia in 20 (9%), punctation in 151 (71%), mosaicism in 9 (4%), and atypical vessels in 44 (21%). histopathological analysis showed hGain in 51/212 of all flat lesions (PPV: 24%). None of the lesions with mosaicism showed HGAIN, whereas lesions with punctation showed a PPV of 30% for HGAIN, lesions with flat leukoplakia a PPV of 25% for HGAIN, and atypical vessels a PPV of 23% for hGain. in contrast, 70% of all hGain lesions showed punctation and 61% showed flat leukoplakia. among flat (noncondylomatous) hGain lesions only, this was even 92% and 80%. When combining characteristics, the combination of punctation, flat leukoplakia, and atypical vessels showed the highest PPV for HGAIN (40%) ( Table 3 ). examples of clinical features with pathological diagnosis are presented in figure 3 .
DISCUSSION
in this study, we analyzed the interobserver agreement in classifying features of intra-anal lesions suspect for ain and compared these features with their histopathological outcome. to our knowledge, no previous studies exist for hRa evaluating the interobserver agreement in classifying lesions. here, we found a substantial interobserver agreement on condylomatous lesions, with a κ coefficient of 0.65. in flat lesions, the κ varied between poor and moderate agreement (κ from 0.08 to 0.54), with moderate consensus being reached for punctation and atypical vessels. this is better than the poor agreement seen in classifying cervical lesions suspect for Cin. 18, 19 after the independent classification, consensus between the 2 observers was reached on all lesions but 2. in the 90 condylomatous lesions found in this study, 18% showed hGain, which is considerable for an assumed benign abnormality. two previous studies retrospectively looked at surgically removed anal condylomata in hiV+ msm and found hGain in 47% and 52%. 20, 21 however, these studies only involved surgically removed condylomata classified as "large, multiple" and "severe condylomatous disease." in our study, all condylomatous lesions were intra-anal and smaller than 1 cm. a third study showed hGain in 22% of recurrent condylomata in hiV+ patients. 22 We found 1 study comparable to ours, which showed a hGain rate of 22% (8/37) in discrete warts and 30% (7/23) in extensive warts, in asymptomatic hiV+ and hiV− men. 23 our study confirms this considerable degree of hGain in discrete, asymptomatic condylomata in a large cohort of hiV+ msm. the implication of these observations is that condylomata in this group should always be biopsied and examined by histopathology. it seems justified to always treat asymptomatic condylomata in hiV+ individuals, not to miss HGAIN. Presently, both the 2010 Centers for Disease Control and Prevention guideline on anogenital warts and the 2012 international union against sexually transmitted infections european guideline on anogenital warts do not recommend this. 24, 25 in flat (noncondylomatous) lesions, punctation as a single characteristic was the best predictor for hGain, with a percentage of 30%, followed by flat leukoplakia (25%) and atypical vessels (23%) as single characteristics. a combination of punctation, flat leukoplakia, and atypical vessels had the highest PPV of HGAIN (40%), followed by punctation and atypical vessels (38%). alternatively, the vast majority of hGain lesions had punctation. a recent study in hiV+ patients showed that hGain was associated with dense acetowhitening and flat, smooth, nonpapillary lesions. however, hGain was only seen in 18 of 128 participants, and the ratio of men and women was not specified. 26 in a much larger study from 1997, macroscopic features of 385 biopsies of 152 msm (vast majority hiV+) were compared with pathological outcome. 12 it showed hGain in 43% of lesions with punctation. a combination of flat acetowhitening and fine punctation showed hGain in 50%, and, in the case of flat acetowhitening and coarse punctation, 49% contained hGain. in the same study, 8% of lesions with punctation represented normal mucosa, whereas, in our study, 51% were nondysplastic. We took more biopsies of fine, regular punctation, which, as on the cervix, can be a feature of normal metaplastic epithelium of the transformation zone. in our experience, patterns of punctation are difficult to recognize and subcharacterizing could lead to lower reproducibility. another difference with our study is the frequency of mosaicism. We only found mosaicism in 3%, none of which represented hGain. in contrast, Jay et al 12 found mosaicism in 20%, 47% of which were hGain. We think that this difference, as well as the difference in nondysplastic punctation mentioned above, might be explained by the fact that in our study features were described by using images of abnormalities, whereas, in Jay's study, features were described during hRa. in this case, the lesion can be looked at in real time, which obviously leads to better recognition of subtle vascular abnormalities. 12 the strong points of our study are the high number of patients; a single, well-trained pathologist evaluating all biopsies; and the fact that 2 dermatologists experienced with hRa independently characterized all lesions. a limitation of our study is that we did not take biopsies of healthy-looking mucosa. in addition, we did not evaluate the use of lugol staining of the mucosa, which is an alternative for acetic acid. furthermore, describing 
CONCLUSION
our study shows that moderate to substantial interobserver agreement between 2 physicians experienced with hRa can be reached. our study also underscores the need for the histopathological evaluation of anal condylomatous lesions in hiV+ men and shows that flat lesions, punctation, and flat leukoplakia are important signs for hGain. these findings may be helpful in establishing evidencebased hRa screening guidelines.
to improve knowledge of the clinical features of ain, we think that future studies should focus on the real-time description of lesions with more than 2 independent observers. furthermore, besides suspect lesions, biopsies of normal-looking mucosa should also be taken for the development of a solid predictive model for ain.
